Lanthanum carbonate oral powder: satisfaction, preference and adherence in French and Spanish patients with end-stage renal disease
Background: Phosphate binders, such as lanthanum carbonate, control elevated serum-phosphate levels in patients with end-stage renal disease (ESRD). Lanthanum carbonate is available in oral powder and tablet form. The aim of this survey was to investigate satisfaction with, preference for, and adher...
Saved in:
Main Authors: | Michael Keith (Author), Patricia de Sequera (Author), Francois Clair (Author), Riccardo Pedersini (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Evaluation of the Safety, Efficacy and Tolerability of Lanthanum Carbonate in the Management of Hyperphosphatemia in Patients with End-Stage Renal Disease
by: Cernaro V, et al.
Published: (2020) -
Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate
by: Ismail A Mohammed, et al.
Published: (2008) -
Abdominal X-ray might be a useful tool for assessing medication adherence in patients receiving Lanthanum carbonate
by: Hiroaki Ogata, et al.
Published: (2012) -
Can Resistance Be Resolved with Lanthanum Carbonate in the Treatment of Hyperphosphatemia? A Multicenter Experience
by: Halil Zeki Tonbul, et al.
Published: (2023) -
Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease-A Comparative Clinical Study
by: Parminder Nain, et al.
Published: (2023)